Terminated PHASE2 INTERVENTIONAL NCT00760318

Keppra for Cervical Dystonia (Keppra)

Prospective Double Blind Evaluation of Levetiracetam (Keppra) for the Treatment of Cervical Dystonia

Sponsor: University of South Florida

Interventions Keppra

Updated 7 times since 2017 Last updated: Nov 21, 2018 Started: Nov 30, 2005 Primary completion: Oct 31, 2007 Completion: Oct 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sponsor decided to stop enrollment to review data.

Other terminated trials from University of South Florida

See all terminations from University of South Florida

A PHASE2 clinical study on Cervical Dystonia, this trial is terminated or withdrawn. The trial is conducted by University of South Florida and has accumulated 7 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Dec 2018 — Jan 2021 [monthly]

Terminated PHASE2

Status: Suspended → Terminated
Jun 2018 — Dec 2018 [monthly]

Suspended PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Suspended PHASE2
Jan 2017 — Feb 2017 [monthly]

Suspended PHASE2

First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of South Florida

Data source: University of South Florida

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.